News & Trends - Biotechnology
Women in Life Sciences celebration inspires more than 440 leaders

Biotech News: AusBiotech and Medicines Australia collaborated to host more than 440 guests at the annual Women in Life Sciences Luncheon on 6 March 2020, in celebration of International Women’s Day.
Co-hosted by Lorraine Chiroiu, CEO, AusBiotech, and Elizabeth de Somer, CEO, Medicines Australia, the luncheon aimed to encourage, support and further develop women in the sector.
The issue of women’s equality is not new, and the approach to addressing it needs to continue to evolve. This year’s theme, inspire, influence, involve, conveyed a movement that is beyond gender, and increasing the number of female leaders in senior positions in life sciences is a conversation everyone should be participating in.
Kirsten O’Doherty, former ANZ General Manager, AbbVie, opened the luncheon as the keynote speaker. “We have come a long way in the past 30 years but we still have a long way to go. The World Economic Forum Global Gender Gap report for 2020 shows Australia is ranked 44th in the world in gender parity. (New Zealand is ranked 6th).” She encouraged women to step out of their comfort zones and push boundaries, be kind to oneself in the face of setbacks, and be loud in calling out poor performance in gender equity.

Ms Lorraine Chiroiu, CEO AusBiotech, said “It is an exciting time in history. Standing on the shoulders of inspirational leaders, the world now expects gender balance and notices its absence. We collectively need to work towards a gender equal world.”
Ms Elizabeth de Somer, CEO of Medicines Australia said: “The Pharmaceutical industry is committed to creating an environment that empowers and enables women to reach the highest levels – this is reflected in the composition of female talent at senior management within our sector. Although there is good work being done, gender inequality remains, and we must continue to address it.”
Six distinguished panellists shared how they have inspired, influenced, and involved others in their push for progress. Resilience, perseverance and self-confidence were key to each panellist’s individual story in reaching their aspirations and inspiring others in their journey.
The panellists included:
- Manuri Gunawardena, Founder and CEO – HealthMatch, Forbes 30 under 30 Class of 2019: Featured Honouree in Healthcare and Sciences
- Dr Dharmica Mistry, Co-founder and Scientific Advisor, BCAL Diagnostics/MedTech Program Manager, Cicada Innovations
- Associate Professor Muireann Irish, ARC Future Fellow and Associate Professor of Psychology, School of Psychology and Brain & Mind Centre, The University of Sydney
- Dr Sarah McDonald, CEO, Baymatob Operations Pty Ltd
- Julie Phillips,CEO and Executive Director, BioDiem Ltd
- Michael Azrak, Vice President and Managing Director Australia and New Zealand, MSD
Enhance corporate branding and boost thought leadership to attract and retain quality employees. How does your company culture measure up in the Australian Pharma industry? Get the benchmark report by contacting us.
Register FREE to receive the latest industry news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News & Trends - MedTech & Diagnostics

Medtech, academia and government unite: Breaking down silos to deliver the power and promise of digital health to patients
MedTech & Diagnostics News: In an interview with Health Industry Hub, Annette Schmiede, CEO of Digital Health Cooperative Research Centre […]
MoreNews & Trends - MedTech & Diagnostics

Two-decade evolution of robotic surgery in Australia’s medical landscape
MedTech & Diagnostics News: In the past two decades, what was once deemed impossible in surgery has now become a […]
MoreNews & Trends - Pharmaceuticals

World-first in IVF: Merging AI and genomics to optimise treatment response for Australians
Pharma News: A world-first Australian IVF study exploring genome sequencing has garnered enthusiastic reception from its collaborative research partners. Securing […]
MoreNews & Trends - Pharmaceuticals

PBS listing marks first oral therapy for childhood arthritis
Pharma News: The first oral Janus kinase (JAK) inhibitor, Pfizer’s Xeljanz (tofacitinib), has been listed on the Pharmaceutical Benefits Scheme […]
More